Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease.

Cikrikcioglu, M A; Karatoprak, C; Cakirca, M; Kiskac, M; Zorlu, M; Cetin, G; Yildiz, K; Erkoc, R; Alay, M; Erkal, S; Erkal, S N; Dogan, S; Kazancioglu, R

Cikrikcioglu, M A; Karatoprak, C; Cakirca, M; Kiskac, M; Zorlu, M; Cetin, G; Yildiz, K; Erkoc, R; Alay, M; Erkal, S; Erkal, S N; Dogan, S; Kazancioglu, R.

Affiliation

Cikrikcioglu MA; Department of Internal Medicine, Bezmialem Vakif University, Faculty of Medicine, Fatih, Istanbul, Turkey. malicikrikcioglu@yahoo.com.

Eur Rev Med Pharmacol Sci ; 17(18): 2530-7, 2013 Sep.

Article de En | MEDLINE | ID: mdl-24089235

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hémoglobines / Inhibiteurs des canaux calciques / Insuffisance rénale chronique Type d'étude: Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Eur Rev Med Pharmacol Sci Sujet du journal: FARMACOLOGIA / TOXICOLOGIA Année: 2013 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Italie

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links